TRAW
Traws Pharma, Inc.
$1.15+0.01 (0.88%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
4 of 49 tradesExecutives investing their own money
🤖 AI InsightHaiku 4.5
Onconova Therapeutics, Inc. (ONTX) is a publicly traded company with 14 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 11 unique insiders. All recorded transactions were open-market purchases, with insiders buying a combined $6.0M of stock — a directionally bullish signal when no offsetting sales occur. The largest single purchase was made by ORBIMED ADVISORS LLC on Apr 16, 2026 for $3.0M. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 49 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | 2026-04-16 | Orbimed Advisors Llc | 10% Owner | Purchase | 597,729 | $1.67 | $1,000,001 | -27.1% | N/A |
| 2026-04-29 | 2026-04-16 | Orbimed Advisors Llc | 10% Owner | Purchase | 597,729 | $1.67 | $1,000,001 | -27.1% | N/A |
| 2026-04-29 | 2026-04-16 | Orbimed Advisors Llc | 10% Owner | Purchase | 1,793,187 | $1.67 | $3,000,002 | -27.1% | N/A |
| 2026-04-29 | 2026-04-16 | Orbimed Advisors Llc | 10% Owner | Purchase | 597,729 | $1.67 | $998,207 | -26.9% | N/A |
| 2026-03-10 | 2026-03-08 | Clarke Trafford | Director | Award | 33,435 | $1.60 | $53,496 | N/A | N/A |
| 2026-03-10 | 2026-03-08 | Cautreels Werner | Director | Award | 31,258 | $1.60 | $50,013 | N/A | N/A |
| 2026-03-10 | 2026-03-08 | Leaman John Harold | Director | Award | 33,435 | $1.60 | $53,496 | N/A | N/A |
| 2026-03-10 | 2026-03-08 | Dukes Iain D. | CEO | Award | 231,336 | $1.60 | $370,138 | N/A | N/A |
| 2026-03-10 | 2026-03-08 | Stover Jack E | Director | Award | 33,435 | $1.60 | $53,496 | N/A | N/A |
| 2026-03-10 | 2026-03-08 | Shoemaker Mary Teresa | Director | Award | 33,435 | $1.60 | $53,496 | N/A | N/A |
TRAW
10% Owner
Purchase
$3M
Orbimed Advisors Llc1,793,187 shares @ $1.67
Filed 2026-04-29Trade 2026-04-16
TRAW
10% Owner
Purchase
$998.2K
Orbimed Advisors Llc597,729 shares @ $1.67
Filed 2026-04-29Trade 2026-04-16
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.